Integra LifeSciences Holdings Corporation
DE ˙ DB ˙ US4579852082
13,30 € ↓ -0,40 (-2,92%)
2026-06-02
DEL PRIS
SecurityDE:IL3 / Integra LifeSciences Holdings Corporation
InstitutionJanus Henderson Group Plc
Latest Disclosed Ownership3,748,284 shares
Ownership 4.40%
Janus Henderson Group Plc ownership in IL3 / Integra LifeSciences Holdings Corporation

2022-02-10 - Janus Henderson Group Plc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,748,284 shares of Integra LifeSciences Holdings Corporation (DE:IL3). This represents 4.4 percent ownership of the company. In their previous filing dated 2021-02-11 , Janus Henderson Group Plc had reported owning 4,622,163 shares, indicating a decrease of -18.91 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2022-02-10 2022-02-10 13G/A 4,622,163 3,748,284 -18.91 4.40 -20.00
2021-02-11 2021-02-11 13G/A 4,312,847 4,622,163 7.17 5.50 10.00
2020-02-14 2020-02-14 13G 4,312,847 5.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 318 -23.92 0.0001
2026-05-15 2026-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 318 -23.92 0.0001
2026-02-17 2025-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 419 -13.46 0.0002
2025-11-14 2025-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 484 16.67 0.0002
2025-08-14 2025-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 414 -43.37 0.0002
2025-05-15 2025-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 731 -4.57 0.0004
2025-02-14 2024-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 766 24.96 0.0004
2024-11-14 2024-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 0 0.00 613 -37.58 0.0003
2024-08-14 2024-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 33,756 -349 -1.02 982 -18.71 0.0005
2024-05-15 2024-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 34,105 0 0.00 1,208 -18.65 0.0007
2024-02-14 2023-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 34,105 -63 -0.18 1,486 13.79 0.0009
2023-11-14 2023-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 34,168 -8 -0.02 1,305 -7.12 0.0009
2023-08-14 2023-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 34,176 -1,669,911 -97.99 1,405 -98.56 0.0009
2023-05-15 2023-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,704,087 -933,972 -35.40 97,830 -33.86 0.0645
2023-02-14 2022-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,638,059 -534,479 -16.85 147,916 10.06 0.1057
2023-01-13 2022-09-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,172,538 -107,610 -3.28 134,389 -24.17 0.1007
2022-11-14 2022-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,172,538 -107,610 134,389 0.1006
2022-08-15 2022-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,280,148 -2,744 -0.08 177,227 -15.99 0.1222
2022-05-16 2022-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,282,892 -465,392 -12.42 210,960 -15.98 0.1019
2022-02-14 2021-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,748,284 -395,441 -9.54 251,097 -11.51 0.1047
2021-11-16 2021-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,143,725 -499,344 -10.75 283,762 -10.44 0.1241
2021-08-16 2021-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,643,069 -14,094 -0.30 316,843 -1.53 0.1356
2021-05-17 2021-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,657,163 35,000 0.76 321,763 7.23 0.1469
2021-02-16 2020-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,622,163 572,291 14.13 300,071 56.91 0.1394
2020-11-16 2020-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,049,872 -145,314 -3.46 191,235 -2.99 0.0997
2020-08-14 2020-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,195,186 -110,740 -2.57 197,132 2.49 0.1107
2020-05-14 2020-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,305,926 -6,921 -0.16 192,346 -23.48 0.1324
2020-02-18 2019-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,312,847 1,086,385 33.67 251,353 29.69 0.1287
2019-11-14 2019-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,226,462 -22,408 -0.69 193,814 6.81 0.1050
2019-07-31 2019-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,248,870 375,546 13.07 181,449 13.33 0.0988
2019-04-30 2019-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,873,324 688,761 31.53 160,102 62.50 0.0887
2019-02-06 2018-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,184,563 175,432 8.73 98,524 -25.55 0.0628
2018-11-09 2018-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,009,131 42,790 2.18 132,341 4.49 0.0707
2018-08-10 2018-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,966,341 365,254 22.81 126,652 42.94 0.0722
2018-05-14 2018-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,601,087 -2,665 -0.17 88,604 15.44 0.0522
2018-03-12 2017-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,603,752 -431,536 -21.20 76,756 -25.29 0.0473
2018-02-09 2017-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 1,603,752 -431,536 76,756
2017-11-14 2017-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,035,288 -20,625 -1.00 102,741 -8.32 0.0658
2017-08-17 2017-06-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,055,913 2,055,913 112,068 0.0764
2017-08-14 2017-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 2,055,913 112,068 0.0765
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.